Chemesis International Inc. announces agreement with The Pelican Group, a leading Vending & Amusement Management Company
February 23, 2021 - Vancouver, BC - Chemesis International Inc. (CSE: CSI.U) (OTC: CADMF) (FRA: CWAB) (the Company or Chemesis), announces that it has reached an agreement with The Pelican Group, a leading Vending & Amusement Management Company, to deploy CBD Vending machines to locations nationwide.
Pelican has been associated with the coin-op industry for 49 years. Their management team is perfectly aligned to oversee and administer the entire Chemesis program and will act as the main contact for operators selected to participate.
Richard Scherer, President of Pelican, commented, Chemesis has been great to work with and we are excited to move forward with this new venture. We will be working with outstanding operators from all over the country who will benefit from this opportunity. We have worked with Josh Rosenberg over the years and are proud to be partnered with his Team yet again to bring their market-leading CBD vending machine to market. Its always a pleasure working with a company providing innovative products that contribute to the operators bottom line.
On Behalf of The Board of Directors
About the Pelican Group
The Pelican Group manages over 50,000 pieces of coin-operated music, amusement and vending equipment for corporate clients through a network of more than 600 professional local coin-machine operators. With offices across the country, they offer a single source of contact, contract administration and accounting for clients with locations in multiple geographical regions.
A privately held California corporation, Pelicans principal office is in Danville, CA.
has approved a marketing budget of US $1,318,943 with CDMG Inc. (CDMG). CDMG will provide the Company with marketing services utilizing its skills to generate investor awareness and attract new investors thru its platforms.
About Chemesis International Inc.
Chemesis International Inc. is a U.S. focused multi-state cannabis company, that is focused on providing an artificially intelligent (AI) based retail solution. The Company currently holds exclusive rights to an AI based kiosk which can be deployed in high traffic areas such as, shopping malls, stadiums, transit hubs, workplaces, and large corporate headquarters.
Chemesis and its team are committed to building a strong unattended and attended retail model for the cannabis market across the United States. Chemesis retail brand, Green Spirit Rx, will continue to provide consumers with industry-leading technology, the most sought-after products and education.
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company''s business, products and future of the Companys business, its product offerings and plans for sales and marketing, including with respect to the Companys expectations regarding its supply and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company''s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected, including, but not limited to, in relation to executing on and maintaining its supply and distribution arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release
Firma: Chemesis International Inc.
Ansprechpartner: Stadt: Wien
Die PresseMitteilung stellt eine Meinungsäußerung des Erfassers dar. Der Erfasser hat versichert, dass die eingestellte PresseMitteilung der Wahrheit entspricht, dass sie frei von Rechten Dritter ist und zur Veröffentlichung bereitsteht. businesspress24.com macht sich die Inhalte der PresseMitteilungen nicht zu eigen. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht businesspress24.com